Crossmark

Change in the serum selenium level of patients with non-metastatic and metastatic non-small cell lung cancer (NSCLC) during radiotherapy as a predictive factor for survival

Crossref DOI link: https://doi.org/10.1007/s00066-024-02276-w

Published Online: 2024-09-06

Published Print: 2025-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ohlinger, Julia

Vordermark, Dirk

Ostheimer, Christian

Bache, Matthias

Tzschoppe, Therese

Demircan, Kamil

Schomburg, Lutz

Medenwald, Daniel https://orcid.org/0000-0001-8920-2853
Seliger, Barbara
Funding

Funding for this research was provided by:

Martin-Luther-Universität Halle-Wittenberg
License Information

Text and Data Mining valid from 2024-09-06

Version of Record valid from 2024-09-06
More Information

Article History

Received: 16 February 2024

Accepted: 7 July 2024

First Online: 6 September 2024

Declarations

:

: J. Ohlinger, D. Vordermark, C. Ostheimer, M. Bache, T. Tzschoppe, K. Demircan, L. Schomburg, D. Medenwald, and B. Seliger declare that they have no competing interests.

: The Ethics Committee of the Medical Faculty of the Martin Luther University approved the study (no.: 2017–15).

Document is current

Any future updates will be listed below